Aralia Quinquefolia, Ginkgo Biloba, Hydrocotyle Asiatica, Cerebrum Suis, Hypophysis Suis, Hypothalamus Suis, Phosphorus, Silicea

FDA Drug Profile — Hypothalmupar

Aralia Quinquefolia, Ginkgo Biloba, Hydrocotyle Asiatica, Cerebrum Suis, Hypophysis Suis, Hypothalamus Suis, Phosphorus, Silicea is listed in the FDA National Drug Code directory with 1 NDC code, marketed under brand name including Hypothalmupar. Available dosage form: liquid.

Drug Details

Generic Name
Aralia Quinquefolia, Ginkgo Biloba, Hydrocotyle Asiatica, Cerebrum Suis, Hypophysis Suis, Hypothalamus Suis, Phosphorus, Silicea
Brand Names
Hypothalmupar
Application Number
Sponsor
Energique, Inc.
NDC Codes
1
Dosage Forms
LIQUID
Routes
ORAL
Active Ingredients
AMERICAN GINSENG, GINKGO, CENTELLA ASIATICA WHOLE, SUS SCROFA CEREBRUM, SUS SCROFA PITUITARY GLAND, SUS SCROFA HYPOTHALAMUS, PHOSPHORUS, SILICON DIOXIDE

Indications and Usage

INDICATIONS: May temporarily relieve weakness, exhaustion, dizziness, and difficult mental concentration.** **Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.

Warnings

WARNINGS: If pregnant or breast-feeding, ask a health professional before use. Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away. Do not use if tamper evident seal is broken or missing. Store in a cool, dry place.